Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Kay

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Neurology|December 19, 2025
Sequence Variants in Small CAG Repeat Expansions of the <i>HTT</i> Gene and Disease Onset and Progression in Huntington DiseaseAnna Heinzmann, Emilien Petit, Jessica Dawson, et al.
Human Molecular Genetics|July 6, 2016
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypesAmber L Southwell, Amy Smith-Dijak, Chris Kay, et al.
Cell Death & Disease|September 26, 2020
pS421 huntingtin modulates mitochondrial phenotypes and confers neuroprotection in an HD hiPSC modelXiaohong Xu, Bryan Ng, Bernice Sim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2024
The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohortJessica Dawson, Chris Kay, Hailey Findlay Black, et al.
American Journal of Human Genetics|November 12, 2019
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington DiseaseChris Kay, Jennifer A Collins, Nicholas S Caron, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 21, 2018
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general populationChris Kay, Jennifer A Collins, Galen E B Wright, et al.
American Journal of Human Genetics|May 21, 2019
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington DiseaseGalen E B Wright, Jennifer A Collins, Chris Kay, et al.
BMJ Open|January 31, 2024
International consensus statement on the design, delivery and evaluation of sport-based interventions aimed at promoting social, psychological and physical well-being in prisonConor Murray, Brendan Coyle, Haydyn Morgan, et al.
Human Molecular Genetics|January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin allelesAmber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Nature Neuroscience|May 5, 2015
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington diseaseKristina Bečanović, Anne Nørremølle, Scott J Neal, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Neurology|December 19, 2025
Sequence Variants in Small CAG Repeat Expansions of the <i>HTT</i> Gene and Disease Onset and Progression in Huntington DiseaseAnna Heinzmann, Emilien Petit, Jessica Dawson, et al.
Human Molecular Genetics|July 6, 2016
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypesAmber L Southwell, Amy Smith-Dijak, Chris Kay, et al.
Cell Death & Disease|September 26, 2020
pS421 huntingtin modulates mitochondrial phenotypes and confers neuroprotection in an HD hiPSC modelXiaohong Xu, Bryan Ng, Bernice Sim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2024
The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohortJessica Dawson, Chris Kay, Hailey Findlay Black, et al.
American Journal of Human Genetics|November 12, 2019
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington DiseaseChris Kay, Jennifer A Collins, Nicholas S Caron, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 21, 2018
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general populationChris Kay, Jennifer A Collins, Galen E B Wright, et al.
American Journal of Human Genetics|May 21, 2019
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington DiseaseGalen E B Wright, Jennifer A Collins, Chris Kay, et al.
BMJ Open|January 31, 2024
International consensus statement on the design, delivery and evaluation of sport-based interventions aimed at promoting social, psychological and physical well-being in prisonConor Murray, Brendan Coyle, Haydyn Morgan, et al.
Human Molecular Genetics|January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin allelesAmber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Nature Neuroscience|May 5, 2015
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington diseaseKristina Bečanović, Anne Nørremølle, Scott J Neal, et al.
Pageof 5